Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
Identifieur interne : 002116 ( Main/Exploration ); précédent : 002115; suivant : 002117Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
Auteurs : Jesse J. Fryk [Australie] ; Denese C. Marks [Australie] ; Jody Hobson-Peters ; Natalie A. Prow ; Daniel Watterson ; Roy A. Hall ; Paul R. Young ; Stefan Reichenberg ; Chryslain Sumian [France] ; Helen M. Faddy [Australie]Source :
- Transfusion [ 1537-2995 ] ; 2016.
Descripteurs français
- KwdFr :
- Bleu de méthylène (pharmacologie), Humains, Inactivation virale (), Inactivation virale (effets des radiations), Lumière, Plasma sanguin (), Plasma sanguin (effets des radiations), Plasma sanguin (microbiologie), Plasma sanguin (virologie), Transfusion sanguine (), Virus de la dengue (), Virus de la dengue (effets des radiations), Virus du chikungunya (), Virus du chikungunya (effets des radiations).
- MESH :
- effets des radiations : Inactivation virale, Plasma sanguin, Virus de la dengue, Virus du chikungunya.
- microbiologie : Plasma sanguin.
- pharmacologie : Bleu de méthylène.
- virologie : Plasma sanguin.
- Humains, Inactivation virale, Lumière, Plasma sanguin, Transfusion sanguine, Virus de la dengue, Virus du chikungunya.
English descriptors
- KwdEn :
- Blood Transfusion (methods), Chikungunya virus (drug effects), Chikungunya virus (radiation effects), Dengue Virus (drug effects), Dengue Virus (radiation effects), Humans, Light, Methylene Blue (pharmacology), Plasma (drug effects), Plasma (microbiology), Plasma (radiation effects), Plasma (virology), Virus Inactivation (drug effects), Virus Inactivation (radiation effects).
- MESH :
- chemical , pharmacology : Methylene Blue.
- drug effects : Chikungunya virus, Dengue Virus, Plasma, Virus Inactivation.
- methods : Blood Transfusion.
- microbiology : Plasma.
- radiation effects : Chikungunya virus, Dengue Virus, Plasma, Virus Inactivation.
- virology : Plasma.
- Humans, Light.
Abstract
Arboviruses, such as dengue viruses (DENV) and chikungunya virus (CHIKV), pose a risk to the safe transfusion of blood components, including plasma. Pathogen inactivation is an approach to manage this transfusion transmission risk, with a number of techniques being used worldwide for the treatment of plasma. In this study, the efficacy of the THERAFLEX MB-Plasma system to inactivate all DENV serotypes (DENV-1, DENV-2, DENV-3, DENV-4) or CHIKV in plasma, using methylene blue and light illumination at 630 nm, was investigated.
DOI: 10.1111/trf.13729
PubMed: 27456861
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001894
- to stream PubMed, to step Curation: 001871
- to stream PubMed, to step Checkpoint: 001871
- to stream Ncbi, to step Merge: 003899
- to stream Ncbi, to step Curation: 003899
- to stream Ncbi, to step Checkpoint: 003899
- to stream Main, to step Merge: 002115
- to stream Main, to step Curation: 002116
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.</title>
<author><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hobson Peters, Jody" sort="Hobson Peters, Jody" uniqKey="Hobson Peters J" first="Jody" last="Hobson-Peters">Jody Hobson-Peters</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Reichenberg, Stefan" sort="Reichenberg, Stefan" uniqKey="Reichenberg S" first="Stefan" last="Reichenberg">Stefan Reichenberg</name>
<affiliation><nlm:affiliation>MacoPharma International GmbH, Langen, Germany; and.</nlm:affiliation>
<wicri:noCountry code="subField">Germany; and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name>
<affiliation wicri:level="1"><nlm:affiliation>MacoPharma, Mouvaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>MacoPharma, Mouvaux</wicri:regionArea>
<wicri:noRegion>Mouvaux</wicri:noRegion>
<wicri:noRegion>Mouvaux</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia. hfaddy@redcrossblood.org.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27456861</idno>
<idno type="pmid">27456861</idno>
<idno type="doi">10.1111/trf.13729</idno>
<idno type="wicri:Area/PubMed/Corpus">001894</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001894</idno>
<idno type="wicri:Area/PubMed/Curation">001871</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001871</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001871</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001871</idno>
<idno type="wicri:Area/Ncbi/Merge">003899</idno>
<idno type="wicri:Area/Ncbi/Curation">003899</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003899</idno>
<idno type="wicri:Area/Main/Merge">002115</idno>
<idno type="wicri:Area/Main/Curation">002116</idno>
<idno type="wicri:Area/Main/Exploration">002116</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.</title>
<author><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hobson Peters, Jody" sort="Hobson Peters, Jody" uniqKey="Hobson Peters J" first="Jody" last="Hobson-Peters">Jody Hobson-Peters</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name>
<affiliation><nlm:affiliation>Australian Infectious Disease Research Centre, School of Chemistry and Molecular Biosciences, and the.</nlm:affiliation>
<wicri:noCountry code="subField">and the</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Reichenberg, Stefan" sort="Reichenberg, Stefan" uniqKey="Reichenberg S" first="Stefan" last="Reichenberg">Stefan Reichenberg</name>
<affiliation><nlm:affiliation>MacoPharma International GmbH, Langen, Germany; and.</nlm:affiliation>
<wicri:noCountry code="subField">Germany; and</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name>
<affiliation wicri:level="1"><nlm:affiliation>MacoPharma, Mouvaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>MacoPharma, Mouvaux</wicri:regionArea>
<wicri:noRegion>Mouvaux</wicri:noRegion>
<wicri:noRegion>Mouvaux</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name>
<affiliation wicri:level="1"><nlm:affiliation>Research and Development, Australian Red Cross Blood Service, Australia. hfaddy@redcrossblood.org.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Research and Development, Australian Red Cross Blood Service</wicri:regionArea>
<wicri:noRegion>Australian Red Cross Blood Service</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Transfusion</title>
<idno type="eISSN">1537-2995</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Blood Transfusion (methods)</term>
<term>Chikungunya virus (drug effects)</term>
<term>Chikungunya virus (radiation effects)</term>
<term>Dengue Virus (drug effects)</term>
<term>Dengue Virus (radiation effects)</term>
<term>Humans</term>
<term>Light</term>
<term>Methylene Blue (pharmacology)</term>
<term>Plasma (drug effects)</term>
<term>Plasma (microbiology)</term>
<term>Plasma (radiation effects)</term>
<term>Plasma (virology)</term>
<term>Virus Inactivation (drug effects)</term>
<term>Virus Inactivation (radiation effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Bleu de méthylène (pharmacologie)</term>
<term>Humains</term>
<term>Inactivation virale ()</term>
<term>Inactivation virale (effets des radiations)</term>
<term>Lumière</term>
<term>Plasma sanguin ()</term>
<term>Plasma sanguin (effets des radiations)</term>
<term>Plasma sanguin (microbiologie)</term>
<term>Plasma sanguin (virologie)</term>
<term>Transfusion sanguine ()</term>
<term>Virus de la dengue ()</term>
<term>Virus de la dengue (effets des radiations)</term>
<term>Virus du chikungunya ()</term>
<term>Virus du chikungunya (effets des radiations)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Methylene Blue</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Chikungunya virus</term>
<term>Dengue Virus</term>
<term>Plasma</term>
<term>Virus Inactivation</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Inactivation virale</term>
<term>Plasma sanguin</term>
<term>Virus de la dengue</term>
<term>Virus du chikungunya</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Transfusion</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Plasma sanguin</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Plasma</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Bleu de méthylène</term>
</keywords>
<keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Chikungunya virus</term>
<term>Dengue Virus</term>
<term>Plasma</term>
<term>Virus Inactivation</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Plasma sanguin</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Plasma</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Light</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Inactivation virale</term>
<term>Lumière</term>
<term>Plasma sanguin</term>
<term>Transfusion sanguine</term>
<term>Virus de la dengue</term>
<term>Virus du chikungunya</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Arboviruses, such as dengue viruses (DENV) and chikungunya virus (CHIKV), pose a risk to the safe transfusion of blood components, including plasma. Pathogen inactivation is an approach to manage this transfusion transmission risk, with a number of techniques being used worldwide for the treatment of plasma. In this study, the efficacy of the THERAFLEX MB-Plasma system to inactivate all DENV serotypes (DENV-1, DENV-2, DENV-3, DENV-4) or CHIKV in plasma, using methylene blue and light illumination at 630 nm, was investigated.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Hall, Roy A" sort="Hall, Roy A" uniqKey="Hall R" first="Roy A" last="Hall">Roy A. Hall</name>
<name sortKey="Hobson Peters, Jody" sort="Hobson Peters, Jody" uniqKey="Hobson Peters J" first="Jody" last="Hobson-Peters">Jody Hobson-Peters</name>
<name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<name sortKey="Reichenberg, Stefan" sort="Reichenberg, Stefan" uniqKey="Reichenberg S" first="Stefan" last="Reichenberg">Stefan Reichenberg</name>
<name sortKey="Watterson, Daniel" sort="Watterson, Daniel" uniqKey="Watterson D" first="Daniel" last="Watterson">Daniel Watterson</name>
<name sortKey="Young, Paul R" sort="Young, Paul R" uniqKey="Young P" first="Paul R" last="Young">Paul R. Young</name>
</noCountry>
<country name="Australie"><noRegion><name sortKey="Fryk, Jesse J" sort="Fryk, Jesse J" uniqKey="Fryk J" first="Jesse J" last="Fryk">Jesse J. Fryk</name>
</noRegion>
<name sortKey="Faddy, Helen M" sort="Faddy, Helen M" uniqKey="Faddy H" first="Helen M" last="Faddy">Helen M. Faddy</name>
<name sortKey="Marks, Denese C" sort="Marks, Denese C" uniqKey="Marks D" first="Denese C" last="Marks">Denese C. Marks</name>
</country>
<country name="France"><noRegion><name sortKey="Sumian, Chryslain" sort="Sumian, Chryslain" uniqKey="Sumian C" first="Chryslain" last="Sumian">Chryslain Sumian</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002116 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002116 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:27456861 |texte= Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27456861" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |